Tesamorelin is a laboratory‑engineered peptide modeled after endogenous Growth Hormone–Releasing Hormone (GHRH). Composed of a stabilized 44‑amino‑acid sequence, Tesamorelin is designed to support advanced research focused on growth hormone regulation, metabolic pathways, and hormonal signal transduction.
Researchers value Tesamorelin for its enhanced stability and resistance to enzymatic breakdown, providing consistent performance in controlled scientific environments. Its structure enables precise examination of pituitary response, metabolic signaling, and various cellular mechanisms related to hormone regulation.
This peptide is provided in high‑purity lyophilized form and is intended strictly for in vitro research, laboratory analysis, and scientific study.
For laboratory research use only. Not for human consumption.


